BACE inhibitors as potential drugs for the treatment of Alzheimer's disease: focus on bioactivity
Current drug development for the treatment of Alzheimer's disease is principally based on
the amyloid cascade theory, and aims to reduce the levels of Aβ amyloid peptide in the …
the amyloid cascade theory, and aims to reduce the levels of Aβ amyloid peptide in the …
3-aryl bicyclic [4, 5, 0] hydroxamic acids as HDAC inhibitors
X Zheng, PY Ng, B Han, JR Thomason… - US Patent …, 2018 - Google Patents
US10112915B2 - 3-aryl bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors - Google
Patents US10112915B2 - 3-aryl bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors …
Patents US10112915B2 - 3-aryl bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors …
3-alkyl-4-amido-bicyclic [4, 5, 0] hydroxamic acids as HDAC inhibitors
X Zheng, PY Ng, B Han, JR Thomason… - US Patent …, 2019 - Google Patents
2017-03-24 Assigned to FORMA THERAPEUTICS, INC. reassignment FORMA
THERAPEUTICS, INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR …
THERAPEUTICS, INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR …
3-alkyl bicyclic [4, 5, 0] hydroxamic acids as HDAC inhibitors
X Zheng, PY Ng, B Han, JR Thomason… - US Patent …, 2019 - Google Patents
2018-10-29 Assigned to FORMA THERAPEUTICS, INC. reassignment FORMA
THERAPEUTICS, INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR …
THERAPEUTICS, INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR …
3-aryl-4-amido-bicyclic [4, 5, 0] hydroxamic acids as HDAC inhibitors
X Zheng, PY Ng, B Han, JR Thomason… - US Patent …, 2019 - Google Patents
US10239845B2 - 3-aryl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors - Google
Patents US10239845B2 - 3-aryl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors …
Patents US10239845B2 - 3-aryl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors …
Bicyclic [4, 6, 0] hydroxamic acids as HDAC inhibitors
X Zheng, PY Ng, A Rudnitskaya… - US Patent 10,183,934, 2019 - Google Patents
6/1982 Schromm et al 8/1989 Rauber et al. 10/1992 DiNinno et al. 9/1993 Booher et al.
3/1994 DiNinno et al. 1/1995 DiNinno et al. 7/1996 DiNinno et al. 3/1997 Yoshimura et al …
3/1994 DiNinno et al. 1/1995 DiNinno et al. 7/1996 DiNinno et al. 3/1997 Yoshimura et al …
Amino-oxazine and amino-dihydrothiazine compounds as beta-secretase modulators and methods of use
R White, Y Cheng, AE Minatti, B Yang… - US Patent …, 2016 - Google Patents
2015-04-09 Assigned to AMGEN INC. reassignment AMGEN INC. ASSIGNMENT OF
ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: LOPEZ, PATRICIA …
ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: LOPEZ, PATRICIA …
Spiro-amino-imidazo-fused heterocyclic compounds as beta-secretase modulators and methods of use
O Epstein, R White, VF Patel, JB Human - US Patent 8,962,859, 2015 - Google Patents
8.436. 447 B2 4, 2013 White et al................... 514,336 Alzheimer's Disease, cognitive deficits
and impairments, 2005/0282825 A1 12/2005 Malamas et al. Schizophrenia and other …
and impairments, 2005/0282825 A1 12/2005 Malamas et al. Schizophrenia and other …
5-amino-oxazepine and 5-amino-thiazepane compounds as beta secretase antagonists and methods of use
T Dineen, M Weiss, VF Patel, XM Zheng… - US Patent …, 2016 - Google Patents
(57) ABSTRACT Related US Application Data (60) Provisional application No. 61/440,270,
filed on Feb. The present invention provides a new class of compounds useful for the …
filed on Feb. The present invention provides a new class of compounds useful for the …
Oxygen-containing fused ring derivative and organic electroluminescence device comprising the same
H Ito, M Kawamura, Y Kawamura, Y Mizuki… - US Patent …, 2016 - Google Patents
US9484540B2 - Oxygen-containing fused ring derivative and organic electroluminescence
device comprising the same - Google Patents US9484540B2 - Oxygen-containing fused …
device comprising the same - Google Patents US9484540B2 - Oxygen-containing fused …